Current progress for the use of miRNAs in glioblastoma treatment
A Tivnan, KL McDonald - Molecular neurobiology, 2013 - Springer
Glioblastoma (GBM) is a highly aggressive brain cancer with the worst prognosis of any
central nervous system disease despite intensive multimodal therapy. Inevitably …
central nervous system disease despite intensive multimodal therapy. Inevitably …
Targeting microRNAs in prevention and treatment of neurodegenerative disorders
ABSTRACT Preclinical Research microRNAs (miRNAs) are small noncoding RNAs
(ncRNAs) that are key regulators of gene expression. They act on wide range of targets by …
(ncRNAs) that are key regulators of gene expression. They act on wide range of targets by …
MicroRNAs as newer therapeutic targets: A big hope from a tiny player
HS Ghelani, MA Rachchh… - … of Pharmacology and …, 2012 - journals.sagepub.com
MicroRNAs (miRNAs) are a novel group of universally present small noncoding
endogenous RNAs that regulate gene expression and protein coding by base pairing with …
endogenous RNAs that regulate gene expression and protein coding by base pairing with …
MicroRNAs in neurodegenerative diseases and their therapeutic potential
E Junn, MM Mouradian - Pharmacology & therapeutics, 2012 - Elsevier
MicroRNAs (miRNAs) are abundant, endogenous, short, noncoding RNAs that act as
important post-transcriptional regulators of gene expression by base-pairing with their target …
important post-transcriptional regulators of gene expression by base-pairing with their target …
Neurodegenerative disorders treatment: the MicroRNA role
B Ridolfi, H Abdel-Haq - Current gene therapy, 2017 - ingentaconnect.com
Neurodegenerative diseases such as Alzheimer's disease, Parkinson's disease,
amyotrophic lateral sclerosis, Huntington's disease and prion disease are not timely and …
amyotrophic lateral sclerosis, Huntington's disease and prion disease are not timely and …
[HTML][HTML] microRNAs involved in Parkinson's disease: A systematic review
FC Da Silva, RR Iop, GG Vietta… - Molecular …, 2016 - spandidos-publications.com
The aim of the present study was to determine the expression of blood microRNAs (miRNAs)
involved in PD in humans. For this purpose the following electronic databases were …
involved in PD in humans. For this purpose the following electronic databases were …
Alterations of miRNAs reveal a dysregulated molecular regulatory network in Parkinson's disease striatum
Molecular adaptations in the striatum mediated by dopamine (DA) denervation and/or
levodopa (L-dopa) treatments have been implicated in the motor deficits found in …
levodopa (L-dopa) treatments have been implicated in the motor deficits found in …
Species-specific miRNAs in human brain development and disease
K Prodromidou, R Matsas - Frontiers in cellular neuroscience, 2019 - frontiersin.org
Identification of the unique features of human brain development and function can be critical
towards the elucidation of intricate processes such as higher cognitive functions and human …
towards the elucidation of intricate processes such as higher cognitive functions and human …
Meta‐analyses identify differentially expressed microRNAs in Parkinson's disease
J Schulz, P Takousis, I Wohlers, IOG Itua… - Annals of …, 2019 - Wiley Online Library
Objective MicroRNA (miRNA)‐mediated (dys) regulation of gene expression has been
implicated in Parkinson's disease (PD), although results of miRNA expression studies …
implicated in Parkinson's disease (PD), although results of miRNA expression studies …
Tiny but mighty: promising roles of microRNAs in the diagnosis and treatment of Parkinson's disease
Y Wang, Z Yang, W Le - Neuroscience Bulletin, 2017 - Springer
Parkinson's disease (PD) is the second most common age-related neurodegenerative
disorder after Alzheimer's disease. To date, the clinical diagnosis of PD is primarily based on …
disorder after Alzheimer's disease. To date, the clinical diagnosis of PD is primarily based on …